Brief: Lee's Pharmaceutical Reports Qtrly Profit Attributable of HK$2.11 Bln
26/08/2021 11:30
Aug 26 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY PROFIT ATTRIBUTABLE HK$2.11 BILLION VERSUS HK$57.1
MILLION
* RECOMMENDED INTERIM DIVIDEND OF HK$0.030 PER SHARE
* QTRLY REVENUE HK$300.9 MILLION, UP 6.1%
Source text for Eikon: ID:nHKS6J2w5V
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA